Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Short-Anchored PEGylated Lipids on Lipid Nanoparticle Characterization Profiles, Stability, and Efficacy.

Biomedicines·2026
Same author

Celiac pseudoaneurysm rupture after ligation in the setting of a pancreatic fistula following penetrating trauma.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Medical and surgical management of aorto-esophageal fistula after denture erosion due to esophageal stent placement.

Journal of vascular surgery cases and innovative techniques·2025
Same author

Office-Based Vascular Surgery Procedures.

The Surgical clinics of North America·2025
Same author

Cardiovascular Symposium on Perspectives in Long COVID.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2025
Same author

Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategy.

JVS-vascular insights·2025

Related Experiment Video

Updated: Oct 12, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K

Liposomal Nanocarriers Designed for Sub-Endothelial Matrix Targeting under Vascular Flow Conditions.

Lauren B Grimsley1, Phillip C West1, Callie D McAdams1

  • 1Department of Surgery, University of Tennessee Graduate School of Medicine, 1924 Alcoa Highway Box U-11, Knoxville, TN 37920, USA.

Pharmaceutics
|November 27, 2021
PubMed
Summary
This summary is machine-generated.

Researchers developed collagen-targeting liposomes (CT-PLPs) for targeted drug delivery after vascular interventions. These nanoparticles show promising binding to collagen IV in simulated flow and ex vivo diseased vessels, aiding vascular remodeling therapies.

Keywords:
hemodynamic flowliposomestargeted drug deliveryvascular shear stressvascular therapeutics

More Related Videos

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
07:00

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

3.4K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.7K

Related Experiment Videos

Last Updated: Oct 12, 2025

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.1K
In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
07:00

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

3.4K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.7K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Vascular Biology

Background:

  • Vascular interventions disrupt the tunica intima, exposing sub-endothelial matrix proteins.
  • Targeted nanoparticles can deliver drugs to inhibit vascular remodeling and improve outcomes.
  • Liposomes are effective delivery systems in vascular cells.

Purpose of the Study:

  • To develop targeted liposomal nanocarriers for preferential collagen IV binding.
  • To evaluate binding under simulated static and dynamic vascular flow conditions.
  • To establish a framework for targeted vascular therapeutics.

Main Methods:

  • Conjugating collagen-binding peptides to PEGylated liposomes (PLPs) to create collagen-targeting liposomes (CT-PLPs).
  • Assessing liposome binding to collagen IV matrices statically and under hemodynamic flow using fluorometric analyses.
  • Evaluating ex vivo binding in human saphenous vein explants within a bioreactor system.

Main Results:

  • CT-PLPs with 5 mol% collagen-binding peptides showed highest collagen IV binding under static conditions.
  • Liposomes maintained favorable nanoparticle characteristics (~50 nm size, ~0.2 PDI) for clinical translation.
  • CT-PLPs demonstrated significant binding under physiological and pathological shear stresses and in diseased vascular tissue ex vivo.

Conclusions:

  • Developed CT-PLPs exhibit preferential collagen IV binding, crucial for targeted vascular interventions.
  • These nanocarriers show potential for spatially controlled drug delivery in vascular repair.
  • CT-PLPs represent a promising platform for future targeted vascular therapeutics.